Cargando…
Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53
SETDB1 is a novel histone methyltransferase associated with the functional tri-methylation of histone H3K9. Although aberrant high expression of SETDB1 was experimentally obversed in a variety of solid tumors, its underlying mechanisms in human carcinogenesis are not well known. In this study, we in...
Autores principales: | Chen, Keli, Zhang, Fengjiao, Ding, Jie, Liang, Yonghao, Zhan, Zetao, Zhan, Yizhi, Chen, Long-hua, Ding, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665049/ https://www.ncbi.nlm.nih.gov/pubmed/29158805 http://dx.doi.org/10.7150/jca.20482 |
Ejemplares similares
-
Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma
por: Zhang, Yuqin, et al.
Publicado: (2018) -
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
por: Fei, Qi, et al.
Publicado: (2015) -
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016) -
Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response
por: Zhao, Zhipeng, et al.
Publicado: (2022)